Stoke Therapeutics Inc

Research Stoke Therapeutics Inc (STOK) on Bullrun: market cap USD 2.02B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSTOK
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 2.02B
• Financial periodFY2025
• RevenueUSD 184.42M
• Revenue growth404.5%
• Net income-USD 6.89M
• Free cash flowUSD 44.92M

Valuation Snapshot

latest market cap is USD 2.02B.

About Stoke Therapeutics Inc

Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in Phase 1 clinical trials for the treatment of autosomal dominant optic atrophy;

Frequently asked questions

What is Stoke Therapeutics Inc's market cap?

Stoke Therapeutics Inc's market capitalization is USD 2.02B.

What does Stoke Therapeutics Inc do?

Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression.